Overview Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) (IMPACT Trial) Status: Recruiting Trial end date: 2025-09-30 Target enrollment: Participant gender: Summary Purpose of this study is to assess the effects of pemvidutide on NASH resolution and NASH fibrosis. Phase: Phase 2 Details Lead Sponsor: Altimmune, Inc.